Citation Impact
Citing Papers
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
2016
Trans-splicing of the C. elegans let-7 primary transcript developmentally regulates let-7 microRNA biogenesis and let-7 family microRNA activity
2019 StandoutNobel
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
2015
Circulating Tumor DNA as a Liquid Biopsy for Cancer
2014
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
2016
Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
2014
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
2016
Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma
2016
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
2015
The dynamic range of circulating tumor DNA in metastatic breast cancer
2014
Breast cancer
2019 Standout
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
2016
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
2016
Cell-free circulating tumor DNA in cancer
2016
Head and neck squamous cell carcinoma
2020 Standout
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
2015
Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
2018
A view on drug resistance in cancer
2019 StandoutNature
Hepatocellular carcinoma
2016 Standout
Liquid biopsy: monitoring cancer-genetics in the blood
2013
Capture and Amplification by Tailing and Switching (CATS)
2014
Predicting treatment resistance and relapse through circulating DNA
2017
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Integrating liquid biopsies into the management of cancer
2017
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
2013
Liquid biopsy enters the clinic — implementation issues and future challenges
2021
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Fragment Length of Circulating Tumor DNA
2016
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Challenges in circulating tumour cell research
2014
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer
2016
Advances in the treatment of advanced oestrogen-receptor-positive breast cancer
2016
Nasopharyngeal carcinoma
2019 Standout
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
2017
Hepatocellular carcinoma
2021 Standout
Cancer stem cells revisited
2017 Standout
Tumour heterogeneity in the clinic
2013 Nature
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
2016
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study
2016
Tumor metastasis: moving new biological insights into the clinic
2013
Lung cancer: current therapies and new targeted treatments
2016 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
2014
Multimodal biomedical AI
2022 Standout
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
2016
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
2015
Implementing Genome-Driven Oncology
2017
Liquid biopsy
2015
Methylation patterns in serum DNA for early identification of disseminated breast cancer
2017
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
2015
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
2018
Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
2017
Emerging Biological Principles of Metastasis
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Precision Medicine — Personalized, Problematic, and Promising
2015
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer
2015
Tumour burden and efficacy of immune-checkpoint inhibitors
2021
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
2019
Integrated digital error suppression for improved detection of circulating tumor DNA
2016
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
2016
PyClone: statistical inference of clonal population structure in cancer
2014
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study
2016
The PI3K Pathway in Human Disease
2017 Standout
Origins, structures, and functions of circulating DNA in oncology
2016
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
2019
Renal cell carcinoma
2017 Standout
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
2014
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
2016
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Hepatocellular carcinoma
2022 Standout
Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
2014
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
2015
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
2015
Cancer biomarkers: Written in blood
2014 Nature
Brain Tumor Imaging
2017
Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor‐sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung cancer during treatment with erlotinib
2014
Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices
2015
Hepatocellular Carcinoma
2019 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
Early Detection of Cancer: Past, Present, and Future
2015
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
2015
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay
2016
Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
2016
Chemotherapy for advanced gastric cancer
2017 Standout
Tumor clone dynamics in lethal prostate cancer
2014
Breast Cancer Treatment
2019 Standout
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome
2016
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
2016
Wound Healing: A Cellular Perspective
2018 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Noninvasive monitoring of infection and rejection after lung transplantation
2015
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
2015
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
2015
Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study
2015
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
2014
Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review
2016
Circulating Tumor DNA as Biomarkers for Cancer Detection
2017
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
2014
A machine learning approach for somatic mutation discovery
2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
2018
Works of Heather Biggs being referenced
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
2016